Viewing Study NCT04860258

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:22 AM
Ignite Modification Date: 2026-05-14 @ 9:35 PM
Study NCT ID: NCT04860258
Status: TERMINATED
Last Update Posted: 2022-05-13
First Post: 2021-04-22
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: COVID-19: A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities
Sponsor: CureVac
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Coronavirus View
None Covid19 View
None SARS-CoV-2 View
None Severe Acute Respiratory Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Covid19 View
None CVnCoV View
None SARS-CoV-2 mRNA vaccine View
None Vaccine View
None SARS View
None COVID View
None Safety View
None Reactogenicity View
None Immunogenicity View